Impact of patent expiry - developed pharmaceutical markets 2008-2017
This statistic shows the financial impact of patent expiry on pharmaceutical products in developed pharmaceutical markets from 2008 to 2012, with forecasts as well for 2013 to 2017. In 2008, spending on branded drugs in developed pharmaceutical markets was 18.5 billion U.S. dollars lower due to the expiry of patents.